Search hospitals > Maine > Rockport
Penobscot Bay Medical Center
Claim this profileRockport, Maine 04856
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
101 reported clinical trials
10 medical researchers
Summary
Penobscot Bay Medical Center is a medical facility located in Rockport, Maine. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Penobscot Bay Medical Center is involved with conducting 101 clinical trials across 175 conditions. There are 10 research doctors associated with this hospital, such as Matthew D. Cheney, Leslie Bradford, MD, Peter Rubin, and Rachit Kumar.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Matthew D. CheneyMaine Medical Center- Scarborough Campus5 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
22 reported clinical trials
60 drugs studied
Leslie Bradford, MDMaine Medical Center- Scarborough Campus2 years of reported clinical research
Expert in Ovarian Cancer
Studies Thyroid Cancer
22 reported clinical trials
52 drugs studied
Peter RubinMaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
17 reported clinical trials
42 drugs studied
Rachit KumarHarold Alfond Center for Cancer Care1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Thyroid Cancer
12 reported clinical trials
46 drugs studied
Clinical Trials running at Penobscot Bay Medical Center
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Thyroid Cancer
ALK Gene Rearrangement
Prostate Adenocarcinoma
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Multiple Myeloma
Anaplastic Large Cell Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Penobscot Bay Medical Center?
Penobscot Bay Medical Center is a medical facility located in Rockport, Maine. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Penobscot Bay Medical Center is involved with conducting 101 clinical trials across 175 conditions. There are 10 research doctors associated with this hospital, such as Matthew D. Cheney, Leslie Bradford, MD, Peter Rubin, and Rachit Kumar.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.